TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr | ₹4,892 Cr |
What is the latest Total Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹4,717 Cr |
| Mar2024 | ₹5,425 Cr |
| Mar2023 | ₹5,447 Cr |
| Mar2022 | ₹4,415 Cr |
| Mar2021 | ₹4,892 Cr |
How is Total Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,717 Cr | -13.05 | |
| Mar2024 | ₹5,425 Cr | -0.40 | |
| Mar2023 | ₹5,447 Cr | 23.38 | |
| Mar2022 | ₹4,415 Cr | -9.74 | |
| Mar2021 | ₹4,892 Cr | - | |
Compare Total Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹129,935.4 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
| MANKIND PHARMA | ₹93,568.2 Cr | 1.4% | -6.9% | -15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.6% |
9.1% |
19.7% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses